UNSPSC 51286505: Novobiocin calcium

This classification denotes an antibiotic 2C31H35N2O11.Ca, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier RHW5BU180N, chemically known as benzamide, n-(7-((3-o-(aminocarbonyl)-6-deoxy-5-c-methyl-4-o-methyl-.alpha.-l-lyxo-hexopyranosyl)oxy)-4-hydroxy-8-methyl-2-oxo-2h-1-benzopyran-3-yl)-4-hydroxy-3-(3-methyl-2-butenyl)-, calcium salt (2:1), but more generally known as novobiocin calcium, which bears US NIH Compound Identifier 20297. Most nations schedule novobiocin calcium under HS 29419000 and SITC 54139.

UNSPSC 51286505 Novobiocin calcium, a Commodity code, shows little relevant recent procurement activity at the state and local level. The four recent opportunities tagged under this code span emergency medical supplies (naloxone and drug deactivation systems), direct-to-manufacturer prescription programs, general medical and first aid supplies for fire rescue, and multi-state cooperative purchasing of generic pharmaceuticals and OTC products — none of which involve novobiocin calcium specifically. The mismatch between the code's nominal scope (a specific antibiotic compound) and the actual procurement activity suggests this code is either rarely used in state and local solicitation tagging or is being applied to acquisitions that do not align with its definition.

Without evidence of recent state and local demand for novobiocin calcium itself, the category presents minimal opportunity signal. Vendors seeking state and local pharmaceutical contracts should monitor the broader generic pharmaceutical and OTC cooperative purchasing vehicles active in the Midwest and South (exemplified by Minnesota Multistate Cooperative Purchasing Alliance procurements and Texas HHS Commission pharmacy initiatives) and direct-to-manufacturer prescription programs, but novobiocin calcium as a discrete commodity does not appear in current state and local solicitation activity.